Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

ClinicalTrials.gov ID: NCT04510376

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04510376. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety Study to Assess the Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects

Study identification

NCT ID: NCT04510376
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Omeza, LLC; Industry
Enrollment: 25 participants

Conditions and interventions

Conditions

Allergic Reaction

Interventions

Device · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 14, 2019 (Actual)
Primary completion: Nov 14, 2019 (Actual)
Completion: Nov 14, 2019 (Actual)
Last update posted: Aug 12, 2020

2019

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
PCR Corp	St. Petersburg	Florida	33702	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04510376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 12, 2020 · Synced Nov 13, 2026